A Ru(II) complex-based COX-2 targeting type I photosensitizer evokes ferroptosis and apoptosis

Fen Qi,Xiaoxue Zheng,Yanping Wu,Shumeng Li,Shankun Yao,Weijiang He,Yuncong Chen,Zijian Guo
DOI: https://doi.org/10.1039/d4cc04217d
2024-11-05
Abstract:Photodynamic therapy (PDT) often faces challenges such as oxygen dependence and limited tumour specificity. We report a tumour-targeting photosensitizer (PS), RuCXB, which enhances uptake by cancer cells by targeting overexpressed cyclooxygenase-2 enzyme in tumours. RuCXB also reduces oxygen dependence via a type I PDT mechanism and achieves a strong therapeutic effect through the synergistic induction of ferroptosis and apoptosis. This work presents a reliable strategy for developing potent PSs with enhanced PDT efficacy, tumour selectivity, and diminished oxygen dependence.
What problem does this paper attempt to address?